Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Oshima, A.
Right arrow Articles by Iura, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oshima, A.
Right arrow Articles by Iura, A.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 31:438-443 (2001)
© 2001 Foundation for Promotion of Cancer Research

Survival of Testicular Cancer Patients in Osaka, Japan

Akira Oshima1, Takako Kitagawa1, Wakiko Ajiki1, Hideaki Tsukuma1, Shota Takenaka2 and Akira Iura2,+,§

1Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases and 2Osaka University School of Medicine, Osaka, Japan

Background: Testicular cancer is one of those cancers for which the prognosis has improved remarkably since the introduction of effective chemotherapy.

Methods: Study subjects were 709 testicular cancer patients who were registered to the population-based Osaka Cancer Registry (OCR) as diagnosed between 1975 and 1992. The testicular cancer patients diagnosed/treated in the Osaka Medical Center for Cancer and Cardiovascular Diseases (OMCC) were also analyzed for comparison.

Results: The 5-year relative survival was 75.2% for the total of 709 patients and 77.9% for those diagnosed during 1990–92. These figures were much lower than those for patients in the USA and in Europe. In contrast, the 5-year survival of the 113 patients diagnosed in the OMCC during 1975–93 was 91.5% and similar to those in the USA and in Europe.

Conclusions: The present study suggests that there are problems in the speed and extent of diffusion of effective chemotherapy for testicular cancer in Osaka.

+ For reprints and all correspondence: Akira Oshima, Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, 1–3–3 Nakamichi, Higashinari-ku, Osaka 537-8511, Japan

§ Abbreviations: OCR, Osaka Cancer Registry; OMCC, Osaka Medical Center for Cancer and Cardiovascular Diseases; DCO, death certificate only; EUROCARE study, European Cancer Registry-based Study of Survival and Care of Cancer Patients; SEER program, Surveillance, Epidemiology and End Results program


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Hum ReprodHome page
T. Iwamoto, S. Nozawa, M. Yoshiike, T. Hoshino, K. Baba, T. Matsushita, S.N. Tanaka, M. Naka, N.E. Skakkebaek, and N. Jorgensen
Semen quality of 324 fertile Japanese men
Hum. Reprod., March 1, 2006; 21(3): 760 - 765.
[Abstract] [Full Text] [PDF]

Home page
 Jpn J Clin OncolHome page
W. Ajiki, H. Tsukuma, and A. Oshima
Survival Rates of Childhood Cancer Patients in Osaka, Japan
Jpn. J. Clin. Oncol., January 1, 2004; 34(1): 50 - 54.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.